Literature DB >> 3311974

Successful pancreatic allografts in combination with bone marrow transplantation in mice.

H Iwai1, R Yasumizu, K Sugiura, M Inaba, T Kumazawa, R A Good, S Ikehara.   

Abstract

We have established a new method for pancreatic allografts in mice by combining pancreatic transplantation with allogeneic bone marrow transplantation. In this approach, we first transplanted bone marrow to induce tolerance to both donor-type and host-type major histocompatibility complex (MHC) determinants. Pancreatic tissue from the same mouse strain as bone marrow donor was then grafted under the renal capsule. Acceptance of the grafts was confirmed by histopathological and immunohistochemical techniques. BALB/c mice reconstituted with C57BL/6J bone marrow cells accepted pancreatic tissue from both bone marrow donor (C57BL/6J)-type and host (BALB/c)-type mice. An immunohistochemical study revealed the presence of functional islets under the renal capsules. Assays for both mixed lymphocyte reaction (MLR) and induction of cytotoxic T lymphocytes indicated that the newly developed T cells are tolerant of both donor (stem cell)-type and host-type MHC determinants. By contrast, the T cells of these chimeras showed a significant responsiveness to third party MHC determinants. These findings suggest that pancreatic allografts combined with bone marrow transplantation may become a viable strategy for the treatment of patients with diabetes or patients who have undergone pancreatectomy.

Entities:  

Mesh:

Year:  1987        PMID: 3311974      PMCID: PMC1454117     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Analyses of Ia restriction specificity of helper T cells in H-2 subregion compatible bone marrow chimera in mice.

Authors:  K Onoé; R Yasumizu; L Geng; K Iwabuchi; M Ogasawara; M Kakinuma; H Okuyama; R A Good; K Morikawa
Journal:  Immunobiology       Date:  1985-02       Impact factor: 3.144

2.  Organ transplantation. Pancreas.

Authors: 
Journal:  Transplant Proc       Date:  1985-02       Impact factor: 1.066

3.  A monoclonal antibody from infected mice to a Schistosoma mansoni egg proteinase.

Authors:  M H Dresden; C K Sung; A M Deelder
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

Review 4.  Allogeneic bone-marrow transplantation.

Authors:  R Storb; E D Thomas
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

5.  Fate of engrafted skin in thymic chimeras.

Authors:  F Furukawa; S Ikehara; H Tanaka; S Inoue; T Nakamura; Y Hamashima
Journal:  Microbiol Immunol       Date:  1984       Impact factor: 1.955

6.  Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody.

Authors:  D L Faustman; R M Steinman; H M Gebel; V Hauptfeld; J M Davie; P E Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Rationale for bone marrow transplantation in the treatment of autoimmune diseases.

Authors:  S Ikehara; R A Good; T Nakamura; K Sekita; S Inoue; M M Oo; E Muso; K Ogawa; Y Hamashima
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

Review 8.  Bone marrow transplantation--an expanding approach to treatment of many diseases.

Authors:  R A Good; N Kapoor; Y Reisner
Journal:  Cell Immunol       Date:  1983-11       Impact factor: 4.868

9.  Murine pancreatic beta-cells express H-2K and H-2D but not Ia antigens.

Authors:  D Faustman; V Hauptfeld; J M Davie; P E Lacy; D C Shreffler
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

10.  Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts.

Authors:  R M Zinkernagel; A Althage; E Waterfield; B Kindred; R M Welsh; G Callahan; P Pincetl
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  4 in total

1.  A strategy for organ allografts without using immunosuppressants or irradiation.

Authors:  H Morita; K Sugiura; M Inaba; T Jin; J Ishikawa; Z Lian; Y Adachi; S Sogo; K Yamanishi; H Taki; M Adachi; T Noumi; Y Kamiyama; R A Good; S Ikehara
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

2.  Treatment of streptozotocin-induced diabetes mellitus in mice by intra-bone marrow bone marrow transplantation plus portal vein injection of beta cells induced from bone marrow cells.

Authors:  M Li; M Inaba; K Q Guo; H Hisha; N G Abraham; S Ikehara
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

3.  Bone marrow stem cell as a potential treatment for diabetes.

Authors:  Ming Li; Susumu Ikehara
Journal:  J Diabetes Res       Date:  2013-04-10       Impact factor: 4.011

4.  Fetal thymus graft enables recovery from age-related hearing loss and expansion of CD4-Positive T cells expressing IL-1 receptor type 2 and regulatory T Cells.

Authors:  Hiroshi Iwai; Muneo Inaba
Journal:  Immun Ageing       Date:  2015-12-15       Impact factor: 6.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.